Srinivas Ayyadevara | Cardiovascular and neurodegenerative disorders | Best Researcher Award

Published on by Cell Biologist

Prof. Dr. Srinivas Ayyadevara | Cardiovascular and neurodegenerative disorders | Best Researcher Award

Prof. Dr. Srinivas Ayyadevara, University of Arkansas for Medical Sciences and CAVHS (GRECC), United States

Dr. Srinivas Ayyadevara is a distinguished Research Health Scientist and Professor whose impactful work in aging, neurodegeneration, and cardiovascular research has spanned over two decades. Currently serving at the Central Arkansas Veterans Healthcare System and the University of Arkansas for Medical Sciences (UAMS), Dr. Ayyadevara is known for his pioneering studies on protein aggregation, mitochondrial dysfunction, and cellular stress responses. His multidisciplinary background in biochemistry, genetics, and molecular biology has enabled him to address critical questions in age-related diseases, particularly Alzheimer’s disease. His career is marked by an exceptional publication record, strong federal research contributions, and a long-standing commitment to mentoring and collaboration. With a proven track record in translational science, Dr. Ayyadevara exemplifies the qualities sought in a top-tier biomedical researcher and continues to make significant contributions to the health and longevity of aging populations.

Publication Profile: 

Google Scholar

Strengths for the Award:

  1. Extensive Research Portfolio:
    Dr. Ayyadevara has a prolific track record of peer-reviewed publications across high-impact journals in fields of aging, neurodegeneration, cardiovascular biology, and molecular mechanisms of disease.

  2. Innovative Contributions:
    His studies have pioneered understanding of protein aggregation, mitochondrial dysfunction, autophagic failure, and pharmacological interventions for Alzheimer’s and age-related pathologies. His recent contributions using neural-network analysis and systems biology approaches are particularly cutting-edge.

  3. Multidisciplinary Expertise:
    With formal education in genetics, chemistry, biochemistry, and molecular biology, and research spanning model organisms to human data, Dr. Ayyadevara’s versatility is a hallmark of modern biomedical research excellence.

  4. Translational Impact:
    His work addresses major public health concerns (e.g., Alzheimer’s, heart disease, aging), with findings that could directly impact therapeutic strategies, particularly for aging populations and veterans.

  5. Longevity of Research Commitment:
    Over two decades of continuous research experience, including long-term federal service with the VA system, reflects sustained productivity and dedication.

  6. Collaborative Leadership:
    He co-authors with multidisciplinary teams, mentors junior scientists, and contributes to community-building within aging and biomedical research.

Areas for Improvement:

  1. Principal Investigator Leadership Visibility:
    While Dr. Ayyadevara contributes significantly to many studies, increased leadership as the sole or lead PI on large federal grants or multi-center collaborations would further highlight his independent research stature.

  2. Recognition and Awards:
    Despite an exceptional track record, public awards, keynote lectures, or national recognition (e.g., from NIH, VA, or gerontological societies) appear underreported. Greater visibility in these areas could bolster his profile.

  3. Patent/Technology Translation:
    The available information does not indicate patent filings or commercialization of findings. Highlighting translational milestones may strengthen his profile for broader impact assessments.

Education:

Dr. Srinivas Ayyadevara’s educational journey began in India, where he earned a B.Sc. (Hons) in Botany, Chemistry, and Biochemistry (1985) and an M.Sc. in Genetics (1987) from Osmania University. He later pursued an M.Sc. in Chemistry at Louisiana Tech University in the U.S. (1993), before completing his Ph.D. in Biochemistry and Molecular Biology at the University of Arkansas for Medical Sciences (1999). His diverse educational background reflects a robust foundation in life sciences, integrating classical genetics with modern molecular biology. This solid academic preparation has greatly informed his experimental approaches in biogerontology and neurodegeneration. His transition from plant and microbial studies to mammalian and human-focused research reflects a clear trajectory toward translational science aimed at combating aging and disease. This interdisciplinary and international academic training positions him well for leadership in cutting-edge biomedical research.

Experience:

Dr. Ayyadevara has over 25 years of biomedical research experience, including more than 17 years as a Research Health Scientist at the Central Arkansas Veterans Healthcare System. Since 2008, he has held this GS-13 level position, contributing to VA research in aging and neurodegeneration. As of July 2025, he serves as a Professor in the Department of Geriatrics at UAMS, following his role as an Associate Professor. His career includes hands-on lab leadership, collaboration with clinical investigators, and senior authorship of high-impact publications. He has led or co-led numerous translational studies involving Alzheimer’s disease, cardiovascular aging, proteomics, and mitochondrial function. Dr. Ayyadevara’s work frequently bridges basic science with clinical relevance, making tangible contributions to veteran health and public aging research. He is a trusted mentor and team leader whose experience spans model organisms, human tissue studies, and molecular interventions aimed at extending healthspan.

Research Focus:

Dr. Srinivas Ayyadevara’s research centers on understanding the molecular underpinnings of aging and age-associated diseases, with a particular emphasis on Alzheimer’s disease, cardiovascular aging, mitochondrial dysfunction, and protein aggregation. He employs model organisms like C. elegans, as well as human and mouse models, to study mechanisms of cellular stress, proteostasis, and genetic resilience to aging. A recurring theme in his work is the role of protein crosslinking and mitochondrial signaling in neurodegenerative and cardiac pathologies. His group is recognized for developing novel tools like the Leave-One-Out-Analysis (LOOA) to study protein interactions in aggregates and identifying actionable targets for drug development. Recently, he has investigated how common pharmaceuticals like ezetimibe and TDZD analogs reduce pathological aggregation. His research merges systems biology, proteomics, and pharmacological screening—offering promising therapeutic avenues for age-related diseases.

Publications Top Notes:

  1.  Mitochondria in aging and age-associated diseases – Mitochondrion, 2025

  2.  Altered protein homeostasis in cardiovascular diseases contributes to Alzheimer’s-like neuropathology – Basic Res Cardiol, 2025

  3.  Ezetimibe reduces Alzheimer’s risk by targeting 14-3-3G::Hexokinase interaction – Aging Biol, 2024

  4.  Model systems reveal pathways to reduce cryoprotectant toxicity – Cryobiology, 2024

  5.  LOOA: A web tool for protein interaction prediction in aggregation studies – Bioinformation, 2024

  6.  Neural-network analysis identifies drug targets in Alzheimer’s amyloid interactome – iScience, 2023

  7.  Small molecules rescue ApoE4-induced autophagy failure in Alzheimer’s disease – Commun Biol, 2024

  8.  Heart attack increases ER stress and aggregation in heart and brain – Mol Cell Biochem, 2023

  9.  TDZD analogs improve neurodegeneration models and extend lifespan in C. elegans – Pharmaceuticals, 2023

  10.  Proteomic analysis of ischemic heart and exosome modulation – Biochem Biophys Rep, 2023

Conclusion:

Dr. Srinivas Ayyadevara is highly suitable for the Best Researcher Award. His consistent, high-impact research over the years, especially in aging, neurodegeneration, and systems biology, combined with his commitment to veteran health and translational outcomes, makes him an outstanding candidate. With a few enhancements in national visibility and leadership designation, his already strong profile could rise to the top tier of internationally recognized researchers.

Paolo Grumati | Organelle Dynamics Function | Organelle Biology Award

Published on by Cell Biologist

Prof. Paolo Grumati | Organelle Dynamics Function | Organelle Biology Award

Prof. Paolo Grumati , TIGEM , Italy

Dr. Paolo Grumati is a leading figure in the field of autophagy and organelle biology, currently serving as Assistant Investigator, Faculty Member, and Head of the Mass Spectrometry Unit at the Telethon Institute of Genetics and Medicine (TIGEM), and as Associate Professor at the University of Naples “Federico II.” His research explores the molecular mechanisms governing selective autophagy, particularly ER-phagy, uncovering its crucial role in protein and organelle quality control. With 65 peer-reviewed publications and an h-index of 35, Dr. Grumati’s work bridges basic and translational science. His cross-national postdoctoral training in Italy and Germany has shaped a robust and internationally recognized research profile. As an active member of prominent scientific societies, frequent invited speaker, and recipient of multiple scientific awards, he exemplifies academic excellence. Dr. Grumati is a strong candidate for the Research for Organelle Biology Award, given his pioneering contributions to understanding cellular organelle dynamics.

Publication Profile:

Orcid

✅ Strengths for the Award:

  1. Pioneering Contributions to Organelle Biology: Dr. Grumati is a leading expert in selective autophagy, especially ER-phagy, a crucial process in organelle quality control.

  2. High-impact Publications: With 65 peer-reviewed publications and an h-index of 35, he has demonstrated consistent, high-level productivity. Notably, his papers in Nature, EMBO Journal, and Nature Communications have advanced understanding in organelle turnover.

  3. Translational Research Relevance: His research has clinical implications in fields like muscular dystrophies, cancer, and metabolic disorders, connecting basic organelle biology to human health.

  4. International Training and Leadership: With postdoctoral experience in Germany and Italy and leadership at TIGEM, he bridges multiple scientific cultures and methodologies.

  5. Recognition and Visibility: Awards like the Early Career Researcher Award (2023) and speaker invitations to EMBO, GRC, and Harden conferences show his scientific visibility and community recognition.

  6. Institutional Impact: He heads the Mass Spectrometry Unit at TIGEM, showing both scientific and technical leadership.

⚠️ Areas for Improvement:

  1. Global Leadership Expansion: While he has strong European recognition, expanding his leadership role in international consortia (e.g., NIH, ERC advanced grants, global editorial boards) would further strengthen his profile.

  2. Cross-organelle Integration: Future work could more explicitly integrate mitochondrial, lysosomal, or Golgi-autophagy mechanisms to broaden his organelle focus across systems biology.

  3. Mentorship Record: Demonstrating mentorship of early-career scientists (e.g., PhD/postdoc supervision) and their outcomes would highlight his long-term impact on the field’s development.

🎓 Education:

Paolo Grumati earned his Master’s degree in Medical Biotechnologies from the University of Padova in 2005, laying the foundation for a research-driven career in molecular biology. He continued at the same institution to complete a PhD in Genetic and Molecular Biology between 2006 and 2009, with a focus on cellular mechanisms underlying disease. After earning his doctorate, Dr. Grumati pursued advanced postdoctoral training across esteemed European institutions. From 2009 to 2013, he worked on muscular dystrophy pathogenesis at the University of Padova. He then joined the Molecular Signaling Group at the Goethe University in Frankfurt (2013–2018), where he specialized in autophagy and organelle biology. His postdoctoral work integrated molecular biochemistry and cell signaling, forming the basis for his future as a principal investigator. Dr. Grumati’s academic trajectory is marked by rigor, international collaboration, and a focus on translational research in cellular organelle quality control.

🧪 Experience:

Dr. Paolo Grumati has over 15 years of research experience in molecular and cellular biology, particularly in selective autophagy. Following his PhD, he held postdoctoral contracts at the University of Padova and Goethe University Frankfurt, focusing on the pathogenesis of muscular dystrophies and autophagy mechanisms. In 2019, he became Principal Investigator at TIGEM, leading research into organelle degradation and ER-phagy. Since 2021, he has held academic appointments at the University of Naples “Federico II”, progressing from Assistant Professor to Associate Professor. His lab combines advanced proteomics, molecular biology, and imaging techniques to explore how autophagy impacts development and disease. He also oversees the Mass Spectrometry Unit at TIGEM, reflecting his leadership in core scientific infrastructure. His academic and institutional roles, paired with his expertise in organelle quality control, demonstrate his sustained contributions and suitability for recognition in the field of organelle biology.

🏅 Awards & Honors:

Dr. Paolo Grumati has received multiple honors for his impactful work in autophagy and organelle biology. In 2023, he was awarded the “Early Career Researcher Award” for best oral communication at the XVII Italian Proteomics Association Annual Meeting in Rome, recognizing the scientific community’s appreciation of his high-impact findings. In 2018, he won the “Oral Communication Award” at the prestigious 83rd Harden Conference in the UK, focused on autophagy in health and disease. He has been selected as a speaker at high-profile international meetings including the EMBO Workshop, GRC Conference on Autophagy, and Frankfurt QC Conference. He also received fellowships for his postdoctoral research in Germany under major international projects like HSFP and SFB. These accolades underline his standing as a thought leader in the autophagy field and affirm his scientific visibility and originality, making him an excellent candidate for the Research for Organelle Biology Award.

🔬 Research Focus:

Dr. Paolo Grumati’s research centers on selective autophagy, particularly the molecular mechanisms that govern endoplasmic reticulum-phagy (ER-phagy) and its role in organelle quality control. His work deciphers how cellular components like FAM134B interact with ER stress and protein homeostasis pathways. By combining biochemical, proteomic, and imaging tools, his research addresses how dysregulation in autophagy contributes to diseases such as cancer, muscular dystrophies, and metabolic disorders. Dr. Grumati’s investigations are crucial for understanding how cells maintain organelle integrity, offering insight into potential therapeutic strategies for diseases linked to organelle dysfunction. His team also examines cross-talk between autophagy and ubiquitination, highlighting his systems-level approach. With funding from major European initiatives and the Telethon Foundation, his group is pushing the boundaries of cell biology by exploring how selective degradation pathways preserve intracellular health. This makes his work highly relevant for recognition through the Research for Organelle Biology Award.

📚 Publications Top Notes:

  1. 🧪 Curvature induction and membrane remodeling by FAM134B reticulon homology domain assist selective ER-phagy – Nature Communications (2019)

  2. 📘 The various shades of ER‐phagy – The FEBS Journal (2019)

  3. 🧬 A selective ER‐phagy exerts procollagen quality control via a Calnexin‐FAM134B complex – EMBO Journal (2019)

  4. 🔍 ER-phagy at a glance – Journal of Cell Science (2018)

  5. 🧫 Extracellular Collagen VI Has Prosurvival and Autophagy Instructive Properties in Mouse Fibroblasts – Frontiers in Physiology (2018)

  6. 🔬 Insights into catalysis and function of phosphoribosyl-linked serine ubiquitination – Nature (2018)

  7. 🔗 Ubiquitin signaling and autophagy – Journal of Biological Chemistry (2018)

  8. 🧠 Full length RTN3 regulates turnover of tubular endoplasmic reticulum via selective autophagy – eLife (2017)

  9. 🦠 Linear ubiquitination of cytosolic Salmonella Typhimurium activates NF-κB and restricts bacterial proliferation – Nature Microbiology (2017)

  10. 💪 Transcription Factor EB Controls Metabolic Flexibility during Exercise – Cell Metabolism (2017)

🧾 Conclusion:

Dr. Paolo Grumati is an outstanding candidate for the Research for Organelle Biology Award. His contributions to understanding the molecular mechanisms of organelle quality control through selective autophagy are both fundamental and translationally relevant. His rigorous training, recognized scholarship, and innovative research direction align strongly with the mission of this award. With continued global engagement and interdisciplinary expansion, he is positioned to become one of the future leaders in organelle biology. This nomination is strongly recommended.

SATISH SAW | Cell Death Pathway | Best Researcher Award

Published on by Cell Biologist

Mr. SATISH SAW | Cell Death Pathway | Best Researcher Award

Mr. SATISH SAW , VINOBA BHAVE UNIVERSITY, HAZARIBAG, JHARKHAND , India

Satish Saw is a Senior Research Fellow in the University Department of Physics at Vinoba Bhave University, Hazaribag, India. He is also a PGT teacher in the Jharkhand Government. His Ph.D. research focuses on “Computational and Experimental studies of Soft- and Hard-Nanomaterials.” With a strong background in Condensed Matter Physics, NanoBio Systems, and Electronics, Satish has demonstrated academic excellence through his education, research, and teaching. He has participated in numerous national and international conferences and workshops. Along with his academic endeavors, Satish has contributed to several publications in reputed journals, enhancing the field of nanomaterials, biodiesel, and environmental sciences. He has received several prestigious awards, including the Gold Medal in M.Sc. and the UGC Junior and Senior Research Fellowships. His dedication to research, along with his teaching responsibilities, highlights his well-rounded commitment to the field of physics.

Publication Profile:

Google Scholar

Strengths for the Award:

  1. Academic Excellence:
    • Gold Medal in M.Sc. and College Topper in B.Sc.: Demonstrates consistent academic achievement.
    • UGC Junior Research Fellowship (2022-2024) and Senior Research Fellowship (2024-Present) show significant recognition of his research capabilities.
    • Completion of Ph.D. with a focus on advanced topics like Condensed Matter Physics and NanoBio Systems.
  2. In-depth Research Contributions:
    • Innovative Research in Nanomaterials: Satish Saw has extensively researched nanomaterials, especially green synthesis of ZnO, Ag-ZnO, and gold nanoparticles. His work in DFT (Density Functional Theory) calculations and experimental techniques has great potential in real-world applications.
    • Cross-disciplinary Collaboration: He has co-authored several papers with diverse researchers, spanning fields like materials science, biotechnology, and environmental science.
    • Multiple research papers under review and accepted, demonstrating high productivity and ongoing contributions to the scientific community.
  3. Research Funding & Recognition:
    • Active participation in high-profile conferences, such as the 66th DAE- Solid state physics symposium, and international events like ASTM-2024 at IIT ISM and Ecotoxicology and Environmental Science Conference at Amity University. These indicate strong networking and engagement with the broader scientific community.
    • His research outputs have already found communication in reputable journals like Physics Letters A and International Journal of Hydrogen Energy, showcasing a broad research impact.
  4. Multidisciplinary Skills:
    • Knowledge of computational methods (Quantum Espresso DFT Software), experimental techniques, and software like Origin Software.
    • Proficiency in multiple areas, including Solid State Physics, Classical Mechanics, Quantum Mechanics, and Mathematical Physics.
  5. Awards & Recognition:
    • Recognition through various fellowships, including UGC JRF & SRF, which are competitive and honor the best researchers.
    • His significant contribution in identifying quasi-specific binding sites of proteins and advancing the understanding of nanomaterial applications makes him stand out.

Areas for Improvement:

  1. Broader Impact and Outreach:
    • While his research is technically impressive, expanding efforts into outreach activities, such as engaging in more public seminars or popular science communication, could further enhance the visibility of his research and its societal impact.
  2. Interdisciplinary Cross-pollination:
    • Although Satish’s research covers a wide range of topics, further interdisciplinary collaborations between bioinformatics and environmental sustainability could push his research into the global forefront, especially concerning sustainable energy solutions or eco-friendly materials.
  3. Publication Diversity:
    • While he has many ongoing or accepted papers, targeting a few high-impact factor journals in his specific fields of interest could elevate the overall reach and recognition of his work.
  4. Experimental Work Expansion:
    • Despite his extensive theoretical knowledge, additional experimental validation, such as large-scale studies or industrial collaborations, could bolster his research’s real-world applicability, especially in nanomaterials for environmental or industrial applications.

Education:

Satish Saw completed his Ph.D. in Condensed Matter Physics and NanoBio Systems at Vinoba Bhave University, Hazaribag. Prior to that, he earned his B.Ed. in Physical Science and M.Sc. in Electronics from the same institution. His undergraduate journey included a B.Sc. in Physics, followed by I.Sc. with a focus on Physics, Chemistry, Mathematics, and Economics. Throughout his academic journey, Satish consistently exhibited strong performance, culminating in his ongoing Ph.D. research in advanced nanomaterials. With a specialization in Solid-State Physics, Quantum Mechanics, and other physics-related disciplines, Satish developed an in-depth understanding of theoretical and experimental physics. His education has paved the way for his diverse academic and professional contributions, including his mastery of software like Quantum Espresso DFT and Origin Software, which aid in his research work. His knowledge base is further supported by his strong foundation in mathematical and classical mechanics.

Experience:

Satish Saw brings a wealth of experience in both academic and research fields. As a Senior Research Fellow at the University Department of Physics, Vinoba Bhave University, Hazaribag, he has conducted extensive research on nanomaterials, both computationally and experimentally. He also serves as a PGT teacher in the Jharkhand Government, where he imparts knowledge in Physics. His professional experience includes attending several prominent national and international conferences, such as the “66th DAE-Solid State Physics Symposium” and the “International Conference on Ecotoxicology and Environmental Science.” Furthermore, he has undergone specialized training in “Research Equipment in Physics & Biotechnology” at CUSB, Gaya. His deep knowledge in Solid-State Physics, Quantum Mechanics, and computational modeling has allowed him to collaborate with professionals worldwide, advancing his field. His expertise is not only theoretical but also hands-on, making him a versatile academician and researcher in modern physics.

Awards & Honors:

Satish Saw has earned numerous awards and honors in recognition of his academic and research excellence. He was awarded the Gold Medal in his Master of Science (M.Sc.) program for academic excellence. Additionally, he was recognized as the College Topper during his Bachelor of Science (B.Sc.) studies. Satish’s dedication to research has earned him the prestigious UGC Junior Research Fellowship (JRF) in January 2022, which he is currently holding. In January 2024, he was promoted to UGC Senior Research Fellowship (SRF), a testament to his continuous contribution to the field. He also qualified for the UGC NET/JRF-2020 and GATE-2020 exams. These accolades reflect his deep commitment to academic growth and research, further positioning him as a leader in his field. Satish’s consistent pursuit of excellence in both academia and research makes him a deserving candidate for various prestigious awards in his field.

Research Focus:

Satish Saw’s primary research focus lies in the computational and experimental study of nanomaterials, particularly in the fields of Condensed Matter Physics and NanoBio Systems. His Ph.D. research is centered on understanding the properties of soft- and hard-nanomaterials through Density Functional Theory (DFT) and other computational techniques, alongside experimental investigations. His work explores the structural, electronic, and optoelectronic properties of nanoparticles, specifically ZnO and Ag-ZnO composites, synthesized using green methods. Additionally, Satish investigates the antibacterial and biocompatibility aspects of these nanoparticles for potential biomedical applications. His research interests extend to the study of biodiesel, specifically its performance and emission characteristics in diesel engines using hydrogen as a secondary fuel. Satish also delves into the synthesis of iodine-doped nanocomposites, focusing on sustainable approaches for material development. His research is pivotal for advancing both materials science and environmental sustainability.

Publications Top Notes:

  1. Morphological, structural, and electronic properties of green synthesized ZnO nanoparticles by experimental and DFT+U method – A review 🌿💎 (Communicated).
  2. Effect on polytropic index, performance, and emission of diesel engine using hydrogen as gaseous fuel with additive di-tert butyl peroxide 🚗⚡ (Communicated).
  3. Identification of quasispecific binding sites of Cro-, λ- and Gal- repressor proteins within Escherichia coli bacterial and Enterobacteria phage λ viral genomes 🧬🔬 (Communicated).
  4. Green synthesis of iodine doped nano-composites using Ocimum basilicum (basil) leaf extract 🌿🔬 (Communicated).
  5. Effect on emissions, combustion, and performance characteristics of Karanja oil biodiesel and Di-tert butyl peroxide assisted using hydrogen as a secondary fuel in a diesel engine 🛢️⚙️ (Communicated).
  6. Experimental and DFT studies of Green Synthesized ZnO nanoparticles for their antibacterial and optoelectronic applications 🦠💡 (Accepted).
  7. Green synthesis of Ag-ZnO Composite nanoparticles using Ocimum basilicum (basil) leaf extract and study their antibacterial effect 🌱💊 (Under Review).
  8. Green synthesis and characterization of gold nanoparticles using leaf extract of Withania somnifera and their in vivo biocompatibility with embryonic zebrafish and antibacterial study 🌟🐟 (Under Review).
  9. Investigation on Pongamia biodiesel with di-tert butyl peroxide on emissions and performance using hydrogen fuel in a diesel engine 🚙🌱 (Under Review).

Conclusion:

Satish Saw stands out as an exemplary researcher due to his academic brilliance, research productivity, and ability to blend theoretical and experimental methodologies in cutting-edge fields like nanomaterials and nanobiotechnology. His consistent achievements, multiple publications in renowned journals, and his engagement with global scientific communities make him a strong candidate for the Best Researcher Award.

 

 

 

Priyanshu Mathur | Cell Death Pathway | Best Researcher Award

Published on by Cell Biologist

Assoc. Prof. Dr. Priyanshu Mathur | Cell Death Pathway | Best Researcher Award

Assoc. Prof. Dr. Priyanshu Mathur , SMS Medical College, Jaipur , India

Dr. Priyanshu Mathur is an esteemed expert in Pediatric Medicine and Genetics, serving as an Associate Professor at SMS Medical College, Jaipur, India. He is renowned for his pioneering work in rare diseases, neurometabolism, and newborn screening. With a robust academic background, Dr. Mathur holds an MD in Pediatrics, a PhD in Genetics (Honorary), and specialized training in clinical biochemical genetics and neurometabolism. He is actively involved in clinical research and education, focusing on inborn errors of metabolism and rare genetic disorders. Dr. Mathur’s leadership extends to founding India’s first Rare Diseases Registry and establishing a newborn screening lab. He has significantly impacted both clinical practice and academic spheres in India and abroad. He is an active member of various international networks and has contributed extensively to medical research and education, solidifying his position as a thought leader in pediatric genetics and rare diseases.

Publication Profile:

Scopus

Strengths for the Award:

Dr. Priyanshu Mathur exhibits a profound commitment to advancing pediatric medicine, particularly in the fields of genetics, neurometabolism, and rare diseases. His extensive academic and clinical contributions make him an exceptional candidate for the Best Researcher Award. Below are the key strengths that highlight his qualifications:

  1. Educational Excellence:
    • Dr. Mathur’s advanced qualifications, including a Masters in Neurometabolism & Cell Biology from the University of Barcelona and a Fellowship in Clinical Biochemical Genetics & Newborn Screening in the USA, underscore his expertise in rare metabolic disorders and genetic diseases.
    • His honorary PhD in Genetics further exemplifies his contributions to genetic research and medicine.
  2. Research and Clinical Leadership:
    • He has been instrumental in establishing the first Indian Rare Diseases Registry, which has provided valuable insights into rare disease prevalence in India (www.rarediseasesregistryindia.com).
    • His work in newborn screening and biochemical genetics, including his leadership in starting the NBS lab at J K Lone hospital, Jaipur, demonstrates a significant impact on early detection and management of genetic disorders.
    • His role as a Principal Investigator (PI) in DBT and ICMR-approved research projects highlights his ability to lead national-level research initiatives.
  3. Publication Record and Recognition:
    • Dr. Mathur has contributed extensively to the scientific literature, with numerous original articles and case reports, often focusing on rare diseases, pediatric genetics, and metabolic disorders.
    • His published works, along with his contributions to textbooks such as Rare Diseases in Pediatrics, exemplify his thought leadership.
    • He is also actively involved in peer review, further demonstrating his academic credibility.
  4. Clinical and Teaching Experience:
    • With years of experience as an Associate Professor at SMS Medical College and as a consultant at J K Lone Hospital, Dr. Mathur has shown excellence in clinical practice and teaching.
    • He is deeply involved in mentoring postgraduate students, guiding them in the fields of genetics and pediatrics, and helping shape the next generation of medical professionals.
  5. National and International Impact:
    • Dr. Mathur’s expertise is internationally recognized, with participation as a speaker and panelist at various international summits, including NBS Virtual Summit and Emory University sessions.
    • His role as a national faculty member for IAP programs and his advisory positions with organizations such as the Rare Disease India Foundation further underscore his leadership.

Areas for Improvement:

  1. Expansion of Research Focus:
    • Although Dr. Mathur has made immense contributions in metabolic genetics and rare diseases, there is potential for further exploration into emerging areas such as gene therapy, CRISPR-based technologies, and personalized medicine.
    • Collaborating with multidisciplinary teams to explore integrative approaches to pediatric genetic disorders could enrich his research portfolio.
  2. Further International Collaboration:
    • Increasing international collaborations, particularly in the context of clinical trials and large-scale multicenter studies, could significantly enhance the global impact of his work. This could provide broader insights and validation of his findings across diverse populations.
  3. Public Outreach and Advocacy:
    • While his contributions to academia are remarkable, further emphasis on public outreach programs to raise awareness about rare diseases and genetic conditions could increase their visibility in India and beyond.
    • Engaging with patient advocacy groups could help bridge the gap between research and patient care.

Education:

Dr. Priyanshu Mathur’s educational journey showcases a deep commitment to advancing knowledge in pediatric medicine and genetics. He earned his MBBS in 2005 from Vijayanagar Institute of Medical Sciences, Bellary, Karnataka, India, where he secured the first rank. He completed his MD in Pediatrics in 2010 from Dr. S. N. Medical College, Jodhpur, Rajasthan, India. His academic pursuits include a Masters in Neurometabolism & Cell Biology for Clinicians from the University of Barcelona, Spain (2022-2024). Dr. Mathur also underwent a Fellowship in Metabolic Genetics and Newborn Screening in Atlanta, USA (2018-2019), strengthening his expertise in the diagnosis and management of genetic disorders. His honorary PhD in Genetics from IIU in 2021 further bolstered his academic stature. His education equips him with an exceptional foundation in clinical genetics, pediatrics, and research, allowing him to contribute meaningfully to the field of medical science.

Experience:

Dr. Priyanshu Mathur’s professional experience spans over a decade, making him a leader in pediatric medicine and genetics. He is currently an Associate Professor at SMS Medical College, Jaipur, where he teaches and mentors future medical professionals. Dr. Mathur’s clinical expertise is evident in his role at J K Lone Hospital, Jaipur, where he oversees the Rare Diseases Clinic and newborn screening services. His experience extends internationally, having worked as a visiting assistant professor in clinical biochemical genetics and newborn screening in Atlanta, USA. He is deeply involved in clinical research, particularly in the field of genetic disorders and rare diseases, and has contributed to several national and international research projects. Dr. Mathur’s teaching roles include guiding postgraduate students and being a faculty member for various national courses and workshops. His work in establishing the first Indian Rare Diseases Registry and newborn screening lab has had a transformative impact on Indian healthcare.

Awards and Honors:

Dr. Priyanshu Mathur has earned multiple prestigious awards throughout his career, recognizing his dedication to research, teaching, and clinical excellence. In 2021, he received an Honorary Doctorate (PhD) in Genetics from IIU for his outstanding contributions to genetics and pediatric medicine. He was awarded a Fellowship in Clinical Biochemical Genetics & Newborn Screening in 2019, marking his specialization in metabolic genetics. In the same year, he received the Outstanding Faculty Award from the Principal of SMS Medical College, Jaipur, for his exceptional contributions to education. Dr. Mathur was also honored with the “Dakshata Praman Patra” at SMS Medical College, Jaipur, in 2016. Earlier in his career, he won the Silver Medal for paper presentation at a State Pediatric Conference in 2009 and was recognized as the Best Outgoing Student at VIMS, Bellary, in 2005. His awards reflect his commitment to advancing medical science and improving healthcare delivery.

Research Focus:

Dr. Priyanshu Mathur’s research primarily focuses on rare diseases, metabolic disorders, and inborn errors of metabolism. He has significantly contributed to the establishment of India’s first Rare Diseases Registry, which provides crucial insights into the prevalence and management of rare genetic conditions in the Indian population. His work in neurometabolism and newborn screening has been groundbreaking, particularly in identifying genetic disorders early and enabling early interventions. Dr. Mathur’s research has expanded the understanding of metabolic genetic diseases and their clinical management, making a considerable impact on patient care. He has also been involved in various clinical trials to evaluate the safety and efficacy of treatments for rare diseases such as Duchenne Muscular Dystrophy and Fabry Disease. His research is not only aimed at better clinical outcomes but also at educating the medical community and raising awareness about rare and inherited disorders. His work continues to shape the landscape of pediatric genetics in India.

Publications Top Notes:

  1. Prevalence of obesity and overweight in private schools of Jaipur city in 11-17 year age group children 📊
  2. Correlation study of various factors with germinal matrix intraventricular hemorrhage in preterm neonates 👶
  3. Evaluation of nutritional & educational intervention as KAP and outcome of children with SAM in malnutrition treatment center 🍽️
  4. Chloroquine vs co-artemether in uncomplicated malaria 🦠
  5. Comparison of risk factors and early morbidity in late preterm neonates and term neonates ⚖️
  6. Prevalence of impaired glucose tolerance test and diabetes in overweight, obese and apparently healthy adolescents 🏫
  7. Prevalence of overweight and obesity amongst adolescents and identification of risk factors 🍔
  8. Assessment of parents and child’s attitude as barrier to dietary compliance in celiac disease 🍞
  9. Study on clinical presentations, risk factors and short term outcome of hemorrhagic disease of newborn 🩸
  10. Epidemiological study of HIV-AIDS in children of western Rajasthan 🌍

Conclusion:

Dr. Priyanshu Mathur’s dedication to advancing pediatric medicine through groundbreaking research in genetics and rare diseases, along with his leadership in newborn screening and education, positions him as an exemplary candidate for the Best Researcher Award. His clinical expertise, substantial publication record, and impact on both national and international healthcare systems demonstrate that he is not only a skilled researcher but also a pioneering figure in improving the lives of children affected by genetic and metabolic disorders. With continued expansion into new areas of research and further global collaborations, Dr. Mathur can continue to make an even greater impact on pediatric healthcare worldwide.